Göran Forsberg
Chief Executive Officer at CANTARGIA AB
Net worth: 99 357 $ as of 31/03/2024
Profile
Dr. Göran Forsberg is an Independent Director at Guard Therapeutics International AB and a Chief Executive Officer at Cantargia AB.
He is on the Board of Directors at Guard Therapeutics International AB.
Dr. Forsberg was previously employed as a Chief Business Officer & VP-Investor Relations by Active Biotech AB, a Non-Executive Director by Isogenica Ltd., a Head-Business Development & Investor Relation by Kabigen AB, and a Head-Business Development & Investor Relation by University of Adelaide.
He also served on the board at Actinova AB, Active Biotech Research AB and Active Security Trading AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CANTARGIA AB
0.17% | 19/01/2024 | 304,412 ( 0.17% ) | 99 357 $ | 31/03/2024 |
Göran Forsberg active positions
| Companies | Position | Start |
|---|---|---|
| CANTARGIA AB | Chief Executive Officer | 09/07/2014 |
| GUARD THERAPEUTICS INTERNATIONAL AB | Director/Board Member | 29/05/2019 |
Former positions of Göran Forsberg
| Companies | Position | End |
|---|---|---|
| Kabigen AB | Investor Relations Contact | - |
| University of Adelaide | Investor Relations Contact | - |
| Actinova AB | Director/Board Member | - |
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Director/Board Member | - |
| Active Security Trading AB | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| Private companies | 5 |
|---|---|
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
| Kabigen AB | |
| Active Security Trading AB | |
Active Biotech Research AB
Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Health Technology |
| Actinova AB |
- Stock Market
- Insiders
- Göran Forsberg
